[Foridon in the combined treatment of patients with chronic obstructive lung diseases].
Noninvasive methods (kinetocardiography, pneumotachometry, sphygmomanometry) were used in 32 patients chronic obstructive pulmonary diseases (chronic obstructive bronchitis, bronchial asthma) to study the effect of foridon (calcium antagonist) on the bronchial patency, lesser and greater circulation arterial pressure during single intakes and course treatment. Single intake had no influence on the bronchial patency while it was influenced by course treatment. Foridon reduced the lesser and greater circulation pressure. It is recommended to include foridon in the complex treatment of patients with chronic obstructive pulmonary diseases complicated by pulmonary hypertension.
Mikunis
R I
RI
Demidiuk
V T
VT
D000293:Adolescent; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D001980:Bronchi / Q000187:drug effects / Q000503:physiopathology; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D002121:Calcium Channel Blockers; D009543:Nifedipine; C045912:ryodipine
Foridon v kompleksnom lechenii bol'nykh khronicheskimi obstruktivnymi zabolevaniiami legkikh.